Usefulness of magnetic resonance imaging for detection of asymptomatic osteonecrosis of the femoral head in patients with inflammatory bowel disease on long-term corticosteroid treatment

Objective. Osteonecrosis of the femoral head is one of the serious side effects of corticosteroid therapy. Early-stage osteonecrosis can now be diagnosed by magnetic resonance imaging even in asymptomatic patients. The aim of this study was to assess the usefulness of magnetic resonance imaging in diagnosing early osteonecrotic change and to determine whether corticosteroid administration is related to the development of osteonecrosis. Material and methods. We examined the relationship between osteonecrosis and corticosteroid administration, including maximum dosage, cumulative lifetime dose, duration, and bone mineral density in 20 patients with refractory inflammatory bowel disease requiring long-term corticosteroid treatment. Osteonecrosis of the femoral head was assessed by magnetic resonance imaging, and bone mineral density by osteodensitometry of the lumbar spine. Results. Osteonecrosis was diagnosed in 5 male patients including 4 in the asymptomatic stage. Cumulative lifetime dose of corticosteroid, duration of corticosteroid treatment, and steroid pulse therapy did not appear to be associated with the development of osteonecrosis. Maximum daily corticosteroid dose was significantly higher for patients with osteonecrosis than for those without it. Administration of 50 mg prednisolone for at least 14 days was a risk factor for osteonecrosis. Development of osteoporosis appeared not to be related to osteonecrosis. Conclusions. We conclude that high-dose corticosteroid treatment increases the risk of osteonecrosis, which may be due to different mechanisms from those responsible for osteoporosis. Magnetic resonance imaging is essential for diagnosis of asymptomatic osteonecrosis in patients receiving high-dose corticosteroids.

[1]  T. Horiuchi,et al.  Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI , 2005, Lupus.

[2]  A. Kornbluth,et al.  Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature , 2005, Alimentary pharmacology & therapeutics.

[3]  D. Hungerford,et al.  Asymptomatic osteonecrosis: should it be treated? , 2004, Clinical orthopaedics and related research.

[4]  K. Freeman,et al.  Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[5]  P. Bullough,et al.  The prevalence and clinicopathological appearance of extension of osteonecrosis in the femoral head. , 1999, The Journal of bone and joint surgery. British volume.

[6]  Hae-Ryong Song,et al.  Angiography, Scintigraphy, Intraosseous Pressure, and Histologic Findings in High‐Risk Osteonecrotic Femoral Heads With Negative Magnetic Resonance Images , 1994, Clinical orthopaedics and related research.

[7]  D. Mitchell,et al.  Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. , 1987, Radiology.

[8]  D. Mitchell,et al.  Hematopoietic and fatty bone marrow distribution in the normal and ischemic hip: new observations with 1.5-T MR imaging. , 1986, Radiology.

[9]  R. Beart,et al.  Vascular complications of inflammatory bowel disease. , 1986, Mayo Clinic proceedings.

[10]  Walteil J. Murphy,et al.  Magnetic resonance imaging of the normal and ischemic femoral head. , 1984, AJR. American journal of roentgenology.

[11]  D. Hungerford,et al.  Asymptomatic Osteonecrosis , 2004 .

[12]  T. Kubo,et al.  Initial MRI findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients. , 1997, Magnetic resonance imaging.

[13]  N. Vakil,et al.  Steroid-related osteonecrosis in inflammatory bowel disease. , 1989, Gastroenterology.